Sarah Long
Primary Care · Oakland Park, FLNPI 1952852634
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,631 and has fallen 98.2% since, to $47 in 2025. Among primary care clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$670
- Johnson & Johnson$643
- Viiv Healthcare Company$504
- Novo Nordisk$267
- AbbVie$249
- Amgen$217
- plus $1K from 21 others
What the payments were for
- Speaking & faculty fees$572%
- Food & beverage$3,61698%
- Education$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 55 | $670 |
| Johnson & Johnson(2 entities) | 43 | $643 |
| Viiv Healthcare Company | 22 | $504 |
| Novo Nordisk | 9 | $267 |
| AbbVie | 15 | $249 |
| Amgen(2 entities) | 16 | $217 |
| EMD Serono, Inc. | 11 | $198 |
| Janssen Products, LP | 2 | $149 |
| Merck | 8 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $117 |
| AstraZeneca | 5 | $81 |
| Theratechnologies Inc. | 4 | $71 |
| Napo Pharmaceuticals Inc | 4 | $57 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Pfizer | 2 | $41 |
| Amarin Pharma, Inc. | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Boehringer Ingelheim | 2 | $34 |
| Pacira Pharmaceuticals Incorporated | 1 | $31 |
| Jazz Pharmaceuticals Inc. | 2 | $27 |
| Averitas Pharma Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Clarus Therapeutics Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| GSK | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,705 in reported general payments places this provider in the 90th percentile of 725 primary care providers in Florida.
Other primary care in Oakland Park
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
- Kristen DeasonTallahassee$10K
- Robert PerriPalm Coast$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.